ViiV Healthcare B.V.
8 products tracked · names used in filings: ViiV Healthcare B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Apretude cabotegravir | Authorised | 2023-09-15 |
| 🇪🇺 | Rukobia fostemsavir | Authorised | 2021-02-04 |
| 🇪🇺 | Vocabria cabotegravir | Authorised | 2020-12-17 |
| 🇪🇺 | Dovato dolutegravir;lamivudine | Authorised | 2019-07-01 |
| 🇪🇺 | Juluca dolutegravir;rilpivirine | Authorised | 2018-05-16 |
| 🇪🇺 | Triumeq abacavir;dolutegravir;lamivudine | Authorised | 2014-08-31 |
| 🇪🇺 | Celsentri maraviroc | Authorised | 2007-09-18 |
| 🇪🇺 | Ziagen abacavir | Authorised | 1999-07-08 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.